Evidence map›Paper›PMID 35928747›Full record

ArticleAnnals of translational medicine2022

Machine learning-based combined nomogram for predicting the risk of pulmonary invasive fungal infection in severely immunocompromised patients.

Chenggong Yan, Peng Hao, Guangyao Wu, Jie Lin, Jun Xu, Tianjing Zhang, Xiangying Li, Haixia Li, Sibin Wang, Yikai Xu and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Chenggong YanDepartment of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Peng HaoDepartment of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Guangyao WuThe D-Lab, Department of Precision Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Jie LinDepartment of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jun XuDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Tianjing ZhangClinical and Technical Solution, Philips Healthcare, Guangzhou, China.
Xiangying LiDepartment of Radiology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, China.
Haixia LiClinical and Technical Solution, Philips Healthcare, Guangzhou, China.
Sibin WangDepartment of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yikai XuDepartment of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Henry C WoodruffThe D-Lab, Department of Precision Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Philippe LambinThe D-Lab, Department of Precision Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Maastricht University · NLSouthern Medical University · CNNanfang Hospital · CNPhilips (China) · CNCentral South University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early and accurate diagnosis of invasive fungal infection (IFI) is pivotal for the initiation of effective antifungal therapy for patients with hematologic malignancies. Methods: This retrospective study involved 235 patients with hematologic malignancies and pulmonary infections diagnosed as IFIs (n=118) or bacterial pneumonia (n=117). Patients were randomly divided into training (n=188) and validation (n=47) datasets. Four feature selection methods with nine classifiers were implemented to select the optimal machine learning (ML) model using five-fold cross-validation. A radiomic signature was constructed using a linear ML algorithm, and a radiomic score (Radscore) was calculated. The combined model was developed with the Radscore, the significant clinical and radiologic factors were selected using multivariable logistic regression, and the results were presented as a clinical radiomic nomogram. A prospective pilot study was also conducted to compare the classification performance of the combined nomogram with practicing radiologists. Results: Significant differences were found in the Radscore between IFI and bacterial pneumonia patients in the training (0.683 Conclusions: The clinical radiomic nomogram can serve as a promising predictive tool for IFI in patients with hematologic malignancies.

Indexed as

computed tomography (CT)hematologic malignancyinvasive fungal infection (IFI)Machine learning (ML)radiomics

Identifiers

PMID35928747
PMCPMC9347049
OpenAlexW4238762063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.